A comprehensive study by Yale Cancer Center has highlighted the superiority of digital breast tomosynthesis (DBT) over traditional 2D digital mammography (DM) in detecting breast cancer. Analyzing 13 years of screening data, researchers found that DBT detected 5.3 cancers per 1,000 screenings compared to 4.0 for DM, while also significantly reducing recall rates for false positives (7.2% for DBT vs. 10.6% for DM). The study indicated that DBT not only catches cancers earlier but also results in fewer advanced cancer diagnoses, with advanced cancers detected at a rate of 32.6% for DBT versus 43.6% for DM. Co-author Dr. Liane Philpotts emphasized that DBT's higher detection rates and lower overdiagnosis rates provide a clear advantage for patient outcomes. The findings were published in the journal 'Radiology' and may influence future breast cancer screening practices.